Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PeptiGrowth | Contract Pharma

What are you searching for?

Sign in

Search by

PeptiGrowth

Company Headquarters

Nihonbashi Life Science Building 7, 9-10, 1 cho-me, Chuo-ku, Tokyo, 103-0012, JP

Driving Directions Phone: View Phone
View website

Request more information from PeptiGrowth

Request more information from PeptiGrowth

Categories from PeptiGrowth

Cell Culture Media Development
Chemicals and Raw Materials
Mammalian Cell Culture
Supplier, Raw Materials
PeptiGrowth: Revolutionizing Regenerative Medicine & Cell Therapy with Synthetic Peptide Growth Factors

Sponsored Content

PeptiGrowth: Revolutionizing Regenerative Medicine & Cell Therapy with Synthetic Peptide Growth Factors

PeptiGrowth, a joint venture between PeptiDream and Mitsubishi Corporation, is focused on the invention of innovative peptide compounds for use in cell culture media. Based in Tokyo, PeptiGrowth was created in 2020 to address challenges in regenerative medicine and cell therapy research, particularly the issues surrounding the use of recombinant protein growth factors, such as […]

Released By PeptiGrowth

Related Content

Collaborations & Alliances

Cellares, SNUH Partner on Cell Therapy Manufacturing

The partners will evaluate Cellares’ Cell Shuttle for scalable manufacturing of a gene-modified PNH therapy.

By: Charlie Sternberg

Breaking News

Made Scientific Acquires Cell Therapy Facility From National Resilience

The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.

By: Charlie Sternberg

Collaborations & Alliances

Ori Biotech Lands 10-Year, $120M Commercial Cell Therapy Manufacturing Deal

The strategic collaboration was agreed upon with an undisclosed biopharmaceutical company.

By: Patrick Lavery

Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius

The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine.

By: Tim Wright

Collaborations & Alliances

Circio, Full Circles Partner on In Vivo Cell Therapy

Collaboration will test Circio’s circVec technology with Full Circles’ immune-evasive C4DNA platform.

By: Charlie Sternberg

Breaking News

IASO Bio Acquires MediSix Therapeutics

Deal adds MediSix’s PEBL platform, T-cell engineering expertise, and clinical-stage pipeline to IASO Bio’s global cell therapy strategy.

By: Charlie Sternberg

Breaking News

NueCell Bio Launches as Specialist Partner in Cell Therapy Acceleration

The team works across a broad scientific spectrum including CAR-T, stem cells, iPSC-derived therapies, gene-edited cells, and tissue repair platforms.

By: Patrick Lavery

Collaborations & Alliances

BriaCell Taps FUJIFILM for Bria-IMT Manufacturing

Deal supports Phase 3 development and potential commercial supply of breast cancer cell therapy.

By: Charlie Sternberg

Collaborations & Alliances

Charles River to Provide GMP NGS Services to Arovella

Partnership covers GMP next-generation sequencing and viral safety testing for Arovella’s ALA-101 cell therapy.

By: Charlie Sternberg

Breaking News

Cellares, SonomaBio Partner on Automated Treg Manufacturing

SBT-77-7101 becomes the first Treg cell therapy program onboarded to the Cell Shuttle platform.

By: Charlie Sternberg

Collaborations & Alliances

Autolomous, Cellular Origins Expand Platform Integration, Enabling End-to-End Cell Therapy Manufacturing

The solution overcomes fragmentation, limited visibility, and the absence of standardized data flows without replacing existing processes.

By: Patrick Lavery

Collaborations & Alliances

Circio, Tcelltech Enter CAR-T Cell Therapy Research Collaboration

Will combine respective technologies to generate in vivo CAR-T and TCR-T cells with enhanced and more durable expression.

By: Kristin Brooks

Collaborations & Alliances

CCRM, OmniaBio, Avectas to Collaborate on Cell Therapy Manufacturing Improvements

Avectas’ automated, integrated, and scalable cell therapy manufacturing platform will be evaluated.

By: Patrick Lavery

Collaborations & Alliances

Syntax Bio Pairs With Mayo Clinic on Stem-Cell Pancreatic Cell Therapies for Type 1 Diabetes

The partners seek to define and subsequently develop an allogeneic pancreatic beta cell therapy based on patient needs.

By: Patrick Lavery

Features

Building Cell Therapy the Right Way

Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.

By: Roger Herr, Patrick Kellish